Plerixafor

Pharm Company: * DR REDDYS LABS LTD
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Plerixafor Overview

Plerixafor (INN and USAN, trade name Mozobil) is an immunostimulant used to mobilize hematopoietic stem cells in cancer patients into the bloodstream. The stem cells are then extracted from the blood and transplanted back to the patient. The drug was developed by AnorMED, which was subsequently bought by Genzyme. Contents 1 Medical uses 2 Contraindications 2.1 Pregnancy and lactation 3 Adverse effects 4 Interactions 5 Pharmacology 5.1 Mechanism of action 5.2 Pharmacokinetics 6 Chemist...

Read more Plerixafor Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Plerixafor

Recent Plerixafor Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Plerixafor
  • Injection: 20mg/ml
  • Solution: 24mg/1.2ml (20mg/ml), 24mg/2.1ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Plerixafor or a similar ingredient: (1 result)